Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The Senior Portfolio & Delivery Manager will join the company's R&D pipeline and advance PMO maturity while ensuring disciplined execution of business system implementations and sustainment initiatives across the organization.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
Revolution Medicines